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Abstract
Rationale: High-fat diet with obesity-associated co-morbidities triggers cardiac remodeling and renders the heart more
vulnerable to ischemia/reperfusion injury. However, the effect of high-fat diet without obesity and associated co-morbidities
is presently unknown.
Objectives: To characterize a non-obese mouse model of high-fat diet, assess the vulnerability of hearts to reperfusion
injury and to investigate cardiac cellular remodeling in relation to the mechanism(s) underlying reperfusion injury.
Methods and Results: Feeding C57BL/6J male mice high-fat diet for 20 weeks did not induce obesity, diabetes, cardiac
hypertrophy, cardiac dysfunction, atherosclerosis or cardiac apoptosis. However, isolated perfused hearts from mice fed
high-fat diet were more vulnerable to reperfusion injury than those from mice fed normal diet. In isolated cardiomyocytes,
high-fat diet was associated with higher diastolic intracellular Ca2+ concentration and greater damage to isolated
cardiomyocytes following simulated ischemia/reperfusion. High-fat diet was also associated with changes in mitochondrial
morphology and expression of some related proteins but not mitochondrial respiration or reactive oxygen species turnover
rates. Proteomics, western blot and high-performance liquid chromatography techniques revealed that high-fat diet led to
less cardiac oxidative stress, higher catalase expression and significant changes in expression of putative components of the
mitochondrial permeability transition pore (mPTP). Inhibition of the mPTP conferred relatively more cardio-protection in the
high-fat fed mice compared to normal diet.
Conclusions: This study shows for the first time that high-fat diet, independent of obesity-induced co-morbidities, triggers
changes in cardiac oxidative state, calcium handling and mitochondria which are likely to be responsible for increased
vulnerability to cardiac insults.
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Introduction
High-fat diet causes cardiac alterations which can be the result
of direct effects on the heart (e.g. by altering cardiac metabolism)
or indirectly as a result of obesity and associated pathologies (e.g.
diabetes, hypertension, cardiac hypertrophy, ischemia, fibrosis and
heart failure) [1–3]. Obesity triggers triglyceride accumulation and
the formation of pro-apoptotic ceramides within cardiomyocytes
which have been implicated in the impairment of contractile
dysfunction [4–7] and possibly causing insulin resistance [4].
Whether obesity induces changes in cardiac function varies
depending on the diet composition, duration of feeding and the
experimental model. Uncoupling of oxidative phosphorylation and
the production of reactive oxygen species (ROS) could combine to
induce contractile dysfunction [8] (reviewed in [3]) possibly by
alterations in Ca2+ cycling [9–11] and/or to lower ATP/oxygen
ratio associated with fatty acid oxidation [12]. In addition to
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changes in Ca2+ cycling, lipid accumulation, apoptosis, oxidative
stress and mitochondrial dysfunction are also potential contribu-
tors to contractile dysfunction [13]. Whether these changes are a
result of obesity and the related co-morbidities or directly due to
the high-fat diet has not been established. High-fat diet triggers
cardiac mitochondrial abnormalities (functional and structural)
under normal and pathological conditions [14,15] which includes
an increase in mitochondrial permeability transition pore (mPTP)
opening in interfibrillar mitochondria [16,17]. The latter could
explain why feeding rodents an obesity-generating high-fat diet
increases vulnerability of hearts to ischemia/reperfusion (I/R)
[18–20] whilst lipid-lowering drugs reduce the incidence of
ischemia-induced ventricular arrhythmias and decrease infarct
size after I/R [21,22]. Significant Ca2+ overload and oxidative
stress are triggers of reperfusion injury that lead to mPTP opening
[23,24]. Overall, it is evident that obesity-induced chronic and
complex metabolic, functional and structural changes in the heart
will render the myocardium more vulnerable to I/R injury. The
vulnerability is independent of whether the perfusate contains
lipids or not [25].
Experimental models used to investigate cardiac remodeling
associated with high-fat diet are either genetically altered or
employ wild-type animals fed high-fat diet. Genetic models
provide important information but they have their limitations
[26]. In the majority of wild-type animal models, rodents are fed
high-fat diet with fat caloric content ranging from 20% to 60%
[8,12,18,26–29]. A standard chow diet would normally contain fat
providing about 12% of total calories (,5% by weight).
Depending on its composition, high-fat diet can result in excessive,
moderate or little weight gain after weeks (or months) of feeding
(e.g. [8,12,15,26,27,29,30]). For example high-fat diet containing
high sucrose carbohydrates would induce excessive weight gain,
diabetes and cardiac dysfunction (e.g. [30–32]). Sucrose is critical
in triggering obesity and/or diabetic phenotype in rats in the
presence [33] or absence of high-fat diet [34]. Additionally, dietary
sucrose (compared to starch) is associated with obesity, insulin
insensitivity, hyperinsulinemia and higher serum lipid and glucose
levels [35,36]. Although excessive weight gain can cause hyper-
tension, the effect is very small in rodents where even obese mice
and rats have little or mild increase in blood pressure [27,28].
The C57BL/6 mouse strain is used as a model for studies of
diet-induced atherosclerosis and/or obesity and diabetes. These
mice become obese, hyperglycemic and insulin resistant when fed
certain types of high-fat diet (e.g. [27,32]) but do not gain extra
weight or show diabetic phenotype when fed high-fat atherogenic
diet (e.g. containing cholesterol and low sucrose) and become
susceptible to atherosclerotic lesion development after long periods
of feeding [30,37]. The overall aims of this research were to
characterize a non-obese mouse model fed high-fat diet and to
determine whether the associated cardiac remodeling of mecha-
nisms underlying I/R injury (oxidative stress, Ca2+ handling and
mPTP) can explain altered vulnerability of hearts and cardiomy-
ocytes to cardiac insults.
Methods
Animals and diet
Breeding, maintenance and feeding of C57BL/6J male mice as
well as weight monitoring and clinical chemistry were all carried
out at Charles River facilities (Charles River, Margate, Kent, UK).
The diet (see below) was delivered directly from the supplier to
Charles River. At the end of the feeding protocols, mice were
delivered and housed for a minimum period of one week at the
Animal Services Unit, University of Bristol. C57BL/6J male mice
were allocated to one of two feeding protocols. During the feeding
protocols the mice were given ad libitum access to food and water
and maintained on a 12 h light/dark cycle. Mice were fed
standard murine chow diet post weaning until 6 weeks of age. The
standard murine chow diet contained 13% calories from fat, 22%
calories from protein and 65% calories from carbohydrate (Special
Diets Services, UK, code: 801900; http://www.sdsdiets.com/
pdfs/VRF1-P.pdf). At 6 weeks of age they were either continued
on standard diet (normal diet mice) or switched to high-fat diet
(high-fat diet mice) for a further 20–21 weeks. The high-fat diet
consisted of 45% calories from fat, 18% calories from protein and
37% calories from carbohydrate (Special Diets Services, UK,
code: 821424). The high-fat diet also contained 0.17% calories
from cholesterol and low sucrose content. The dietary fat was from
lard and consisted of a mixture of saturated (44%) and mono-
(43%) and poly-unsaturated (13%) fatty acids. More details of
high-fat diet composition are shown in Table S1. The gross energy
for high-fat and normal diets was 19.67 and 16.54 kJ?g21,
respectively. Crude fat content (by weight) in different batches
ranged between 21–23%. This high-fat diet is known to promote
atherosclerosis in transgenic mice models without inducing
significant body weight gain [38–41].
Ethics Statement
Animal work was performed in accordance with the UK
Animals (Scientific Procedures) Act of 1986 and approved by the
University of Bristol Animal Welfare and Ethical Review Board
(Permit numbers: PPL 30/2859 and PIL 30/6547).
In vivo measurements
Clinical chemistry measurements. Tail vein blood was
taken from non-fasted mice and pooled (one pooled sample was
from three animals) to measure cholesterol, triglycerides and
glucose performed by Charles River (Margate, UK). An intra-
peritoneal insulin tolerance test (IPITT) was also performed on
animals from the two groups (approx. 25 weeks old). For this
purpose, blood glucose was measured from the tail vein of mice
that had been fasted for 4 h. Insulin was then administered by an
intra-peritoneal injection at a concentration of 1 IU?kg21 and
blood glucose was measured at 15, 30, 60 and 120 min post insulin
injection.
Echocardiography. 2-D echocardiography was performed
using a Vevo 770 High-Resolution In Vivo Imaging System
(VisualSonics, Canada) on mice one week before use for other
experiments (approx. 25 weeks old). Mice were anesthetized by
inhalation of isoflurane and kept warm using a heat pad set at
37uC. M-mode recordings of the hearts were taken using a
parasternal short axis view at the level of the papillary muscles. For
each heart at least five separate M-mode measurements were
taken. Following anesthesia mice were closely monitored until full
recovery was observed. Heart rates for the majority of anesthetized
mice were in the range of 400–475 bpm. Mice with heart rates
outside this range were excluded from the analysis.
Histology. Following a ventral midline thoracotomy, and
incision of the jugular veins, mice were perfused and fixed at
physiological pressure, via the left ventricle, with 10% formalin.
Tissue was excised and post-fixed in formalin for at least 16 h
prior to histological processing [42]. Sections were stained with
elastic van Gieson for morphology and identification of lesions in
aortic sinuses, coronary arteries and brachiocephalic arteries from
mice fed high-fat diet.
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Experiments on isolated hearts
Langendorff perfusion. Hearts were excised from freshly
sacrificed mice, placed in ice cold Krebs-Henseleit buffer,
cannulated via the aorta onto a Langendorff system (ADInstru-
ments, UK) and perfused with 37uC Krebs-Henseleit buffer,
consisting of, in mM, 120 NaCl, 25 NaHCO3, 11 D-glucose
anhydrous, 1.2 KH2PO4, 1.2 MgSO4?7H2O, 4.8 KCl and 2
CaCl2. The buffer solution in the reservoirs was gassed with 95%
O2 and 5% CO2 (pH 7.4). Hearts were perfused with a constant
filling pressure of 60 mmHg and coronary flow monitored
throughout.
Ischemia/reperfusion protocol. The hearts were perfused
with Krebs-Henseleit buffer for a 30 min stabilization period,
followed by 40 min of no flow global ischemia and 120 min
reperfusion. For experiments using cyclosporin A (CsA) the drug
was present 10 min before ischemia and remained in the perfusate
until 20 min into reperfusion. The CsA was dissolved in DMSO
(1:10,000 final dilution) and added to the buffer at a concentration
of 0.2 mM. During the experiment hearts were bathed in 37uC
buffer and coronary flow rate and filling pressure were measured
by Chart 5 software (ADInstruments, UK).
Myocardial injury. Triphenyl tetrazolium chloride (TTC)
staining was used to determine the infarct size within the heart as
described previously [43]. Briefly, at the end of reperfusion hearts
were perfused with a 1% (w/v) TTC PBS solution for 10 min,
frozen and then cut into 5 equally sized transverse slices. Infarct
size was calculated using ImagePro Plus software (Media
Cybernetics, USA). In addition to cardiac injury, vascular
dysfunction was also monitored by comparing the extent of
recovery in coronary flow rate following I/R.
Western blotting. Ventricular tissue was collected from
freshly sacrificed mice or following I/R, snap frozen in liquid
nitrogen and stored at 280uC. Tissue was homogenized in 10 mL
radio-immunoprecipitation assay (RIPA) buffer per mg wet weight
and centrifuged at 10,0006g for 10 min at 4uC. Proteins in the
supernatant or mitochondrial proteins (10 mg) were separated
using SDS-polyacrylamide gel electrophoresis under reducing and
denaturing conditions and transferred to a 0.45 mm polyvinylidene
difluoride membrane. The membranes were blocked with tris-
buffered saline (TBS)-Tween, containing either 10% (w/v)
skimmed milk powder or 5% (w/v) BSA, before incubation
overnight (4uC) with a primary antibody diluted in TBS-Tween
containing 5% (w/v) BSA. Primary antibodies used included
phosphorylated (Ser473) Akt (1:2000, Cell Signaling), Akt (1:2000,
Cell Signaling), cleaved caspase 3 (CC3) (1:1000, Cell Signaling),
Bcl-2-associated X protein (BAX) (1:2000, Cell Signaling), B-cell
lymphoma-2 (Bcl-2) (1:2000, Cell Signaling), mitofusin 1 (Mfn-1)
(1:1000, Abcam), Mfn-2 (1:1000, Abcam), optic atrophy 1 (OPA1)
(1:10,000, Abcam), dynamin related protein 1 (DRP1) (1:1000,
Cell Signaling), phosphate carrier (PiC) (1:100,000, Sigma-
Genosys), voltage-dependent anion channel (VDAC) (1:4000, Cell
Signaling), cyclophilin D (CypD) (1:2000, Abcam), adenine
nucleotide transferase (ANT) (1:10,000, custom made (see [44])),
hexokinase II (1:1000, Cell Signaling), phosphorylated (Ser16)
phospholamban (P-PLN) (1:2000, Abcam), PLN (1:5000, Abcam)
and catalase (1:2000, Abcam). For whole heart tissue glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) was used as a loading
control (1:10,000, Cell Signaling) and for mitochondrial fractions
total protein blots were used. Blots were then incubated with an
appropriate horseradish peroxidase conjugated secondary anti-
body (1:10,000, GE Healthcare Life Sciences) and proteins were
visualized using the enhanced chemiluminescence system. Protein
bands were quantified by densitometry with ImageJ 1.46r
software.
Malondialdehyde assay. Cardiac malondialdehyde (MDA)
was measured using high-performance liquid chromatography
(HPLC) on a 4 mm Nova-Pak C18 column (150 mm63.9 mm)
(Waters, UK) as described elsewhere [45]. In brief, the extract was
prepared by adding 50 mL of 6 M NaOH to 250 mL of
0.8 mg?mL21 tissue sample diluted in RIPA buffer and incubated
at 60uC for 30 min. The protein was then precipitated with
125 mL of 35% (v/v) perchloric acid and the mixture was
centrifuged at 28006g for 10 min. 250 mL supernatant of each
standard and sample was mixed with 25 mL 2,4-dinitrophenylhy-
drazine (prepared as a 5 mM solution in 2 M HCl). This mixture
was incubated for 30 min at room temperature in the dark and
then centrifuged at 40006g for 5 min. 50 mL of standards and
samples were injected into the HPLC system. The mobile phase
was 12.4% (v/v) acetic acid and 38% (v/v) acetonitrile and was
perfused through the column at a flow rate of 0.6 mL?min21 at
room temperature. Chromatograms were acquired by measuring
absorbance at 310 nm.
Proteomics. Protein analysis was performed by the proteo-
mics facility, School of Medical Sciences, University of Bristol.
Isobaric Tandem Mass Tags (TMTs) (ThermoFisher Scientific,
UK) with an amine-reactive moiety were used for analysis of
protein expression in extracted cardiac tissue. Each sample was
initially digested with trypsin (0.025 mg?mg of protein21 at 37uC
overnight, Promega, UK) and then labelled with TMT sixplex
reagents according to the manufacturer’s protocol (Thermo
Scientific UK). The samples were then analyzed by reverse phase
nano-liquid chromatography mass spectrometry/mass spectrom-
etry using a LTQ-Orbitrap Velos mass spectrometer (Thermo
Scientific, UK). The peptide fragments released the isobaric tags
which were used to provide quantification of the peptides. The
peptides were searched against the UniProt/SwissProt mouse
database (81,998 entries) using the SEQUEST (Ver. 28 Rev. 13)
algorithm to determine the source protein. Protein quantitation
was the median value of peptide(s) identified from the same
protein. The peptides were analyzed using Thermo Proteome
Discoverer 1.2.0.208 software (ThermoFisher Scientific, UK) and
quantified proteins were recorded as a ratio to create fold change
against a standard sample (created by pooling an equal volume
from each sample) and normalized to GAPDH.
Electron microscopy. Hearts were excised from freshly sacri-
ficed mice, cannulated via the aorta and retrogradely perfused
with 37uC Krebs-Henseleit buffer, as in the Langendorff perfusion
section. The hearts were perfused for 5 min with buffer and then
for 2 min with the fixative solution at a rate of 1 mL?min21. The
fixative solution was made up of 0.1 M phosphate buffer
(22.5 mM NaH2PO4?2H2O and 76.76 mM Na2HPO4, pH 7.4)
with the following added to it: 0.5 mM CaCl2, 1.7 mM D-glucose
anhydrous, 1% (v/v) glutaraldehyde from a 25% stock solution
and 1% (w/v) paraformaldehyde. Subsequently, a ,2 mm slice
was taken after removing the apex of the heart. The heart slices
were stored overnight at 4uC in fixative solution. This was
followed by more washing and dehydration and the final part of
the fixation was to embed the tissue in EPON epoxy resin and
polymerize at 60uC for 48–72 h. Thick sections (2.5 mm) were cut
with a microtome (Leica, Germany) so that the cardiomyocytes
were orientated into a longitudinal plane. Thin sections (70 nm)
were cut and stained with uranyl acetate and lead citrate (94 mM
lead nitrate, 140 mM sodium citrate and 0.19 mM NaOH) and
viewed with a Tecnai 12 bioTWIN transmission electron
microscope (FEI, Netherlands) in the Wolfson Bioimaging Facility
at the University of Bristol. Images were taken with an Eagle
4K64K charged coupled device camera (FEI, Netherlands). From
the electron micrographs the area, lengths and density (mitochon-
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drial coverage of total myofilament area) of interfibrillar
mitochondria were measured using ImagePro Plus Version
6.2.0.424 software (Media Cybernetics, USA).
Experiments on isolated cardiomyocytes
Cardiomyocyte isolation. Ventricular cardiomyocytes were
isolated using collagenase (1 g?L21, type-1, Worthington Bio-
chemical Corporation, New Jersey, USA) and protease
(0.05 g?L21, type XIV, Sigma-Aldrich, Dorset, UK) digestion as
described previously [46]. The only modification was that the
perfusion speed was 2.3 mL?min21 and there was no CaCl2 in the
enzyme solution. Once digested, the ventricular tissue was
separated and mechanically dispersed by shaking at 37uC.
Cardiomyocytes were filtered and then the CaCl2 concentration
in the buffer was gradually increased to a final concentration of
1 mM.
Superfusion and stimulation of cardiomyocytes. Cardio-
myocytes were superfused at a rate of 1.3 mL?min21 with HEPES
buffer solution consisting of, in mM, 137 NaCl, 5 KCl, 1.2
MgSO4?7H2O, 1.2 NaH2PO4?2H2O, 20 HEPES, 15 D-glucose
anhydrous and 2 CaCl2 (pH 7.4) [47]. The microscope stage was
heated by a temperature controller so that the solution bathing the
cells was 32–33uC. The stimulation voltage was set at just above
the threshold required for the cell to beat.
Changes in cardiomyocyte morphology during metabolic
inhibition. Cardiomyocytes were initially superfused with
HEPES buffer solution and field stimulated at 0.2 Hz throughout
the protocol. The solution superfusing the cells was switched from
HEPES buffer to HEPES buffer containing 2 mM NaCN and no
glucose (metabolic inhibition) which has been shown to mimic the
effects of hypoxia [47,48]. After a period of metabolic inhibition
the cardiomyocyte goes into rigor. After 10 min in rigor, the
perfusion was switched back to HEPES buffer (reperfusion) for
10 min. Parameters such as time to stop beating, time to rigor and
contractile recovery after reperfusion were recorded.
Intracellular Ca2+measurements. Isolated cardiomyocytes
were loaded with the fluorescent dye Fura-2 AM ester (Biotium
Inc., USA) at a concentration of 2 mM and gently shaken at 37uC
for 15 min. Loaded cardiomyocytes were superfused with HEPES
buffer, stimulated at different frequencies and the intracellular
Ca2+ concentrations ([Ca2+]i) were measured (for a representative
trace see Results section). The ratio of 340:380 was used as an
indication of [Ca2+]i. The excitation wavelengths were set so that
20 ratio measurements were taken per second. The excitation
dichroic mirror was 415 nm and the emission passed through a
510620 nm bandpass filter. The photomultiplier was connected
to Felix 32 Analysis version 1.2 software (Photon Technology
International, USA).
ROS turnover in a cardiomyocyte suspension. The
fluorescent dye 5-(and 6)-chloromethyl-29, 79-dichlorodihydro-
fluorescein diacetate (CM-H2DCFDA) (5 mM) (Life Technologies,
UK) was added to a cardiomyocyte suspension for 15 min at room
temperature. After loading, the solution was centrifuged at 1006g
for 1 min at room temperature and the cell pellet was resuspended
in HEPES buffer or HEPES buffer without glucose but
supplemented with 0.5 mM palmitate bound to 1% (w/v) fatty
acid free BSA, as described previously [49]. 200 mL aliquots of the
cardiomyocyte suspension were added to a 96-well plate, excited at
485 nm and fluorescence was detected at 520 nm using a
fluorescent plate reader (37uC) (FLUOstar Optima, BMG
Labtech, Germany).
Experiments on isolated mitochondria
Mitochondrial isolation. Two methods were used to isolate
mitochondria, a protease method and a Polytron method, as
described previously for rat heart mitochondria [50]. The protease
method was preferred as it yielded more mitochondria; however, if
outer mitochondrial membrane proteins were to be analyzed,
proteolytic cleavage of the proteins might occur and so the
Polytron method was used. Hearts were excised from freshly
sacrificed mice, cannulated via the aorta and perfused with
isolation buffer to wash out blood. The isolation buffer consisted of
300 mM sucrose, 10 mM Tris-HCl and 2 mM EGTA and the pH
was 7.2 at 4uC. For the Polytron method the isolation buffer was
supplemented with protease (cOmplete EDTA-free, Roche, UK)
and phosphatase (phosphatase inhibitor cocktail 3, Sigma, UK)
inhibitors. The centrifuge steps were carried out as in [50] with
density-gradient purification of mitochondria in 25% (v/v) Percoll.
Oxygen consumption rates in isolated cardiac
mitochondria. Mitochondria prepared with the protease meth-
od were used to determine the O2 consumption rates at 37uC
using a High-Resolution Respirometry Oxygraph-2K (Oroboros
Instruments, Austria), as described previously [51]. Mitochondria
(0.125 mg?mL21 final) were added to 2 mL of KCl buffer in the
chamber and the O2 consumption was recorded. The KCl buffer
contained, in mM, 125 KCl, 20 MOPS, 10 Tris, 0.01 EGTA, 2.5
KH2PO4, 2.5 MgCl2 and 2% (w/v) fatty acid free BSA. The buffer
was set to pH 7.1 at 37uC with KOH. The O2 consumption was
recorded in state 2 to assess basal respiration, state 3.5 thought to
mimic ATP turnover in vivo and state 3 respiration to assess
maximal respiration rates. To obtain state 2 respiration mito-
chondria (0.125 mg?mL21) were added to the chamber containing
the KCl buffer. For respiration linked to NADH oxidation 5 mM
pyruvate and 2.5 mM L-malate were added and for respiration
linked to fatty acid b-oxidation 10 mM palmitoylcarnitine was
added instead of pyruvate and the L-malate concentration was
reduced to 1 mM. When a steady state of O2 consumption was
reached a measurement of state 2 was taken. From the stable rate
the O2 consumption was determined in either state 3.5 or state 3.
For state 3.5 respiration 5 mM creatine, 40 mg creatine kinase and
400 mM ATP were added to the chamber. To obtain state 3
respiration 1.5 mM ADP was added. When the O2 consumption
again reached a stable rate 10 mM (final concentration) cyto-
chrome c was added to determine the amount of outer
mitochondrial membrane damage.
Hydrogen peroxide production by isolated cardiac
mitochondria. Mitochondria prepared using the protease
method were used to measure the rate of hydrogen peroxide
production in state 3.5 from respiration linked to NADH oxidation
and fatty acid b-oxidation (as above) and supplemented with
30 mM Amplex Red and 0.1 mg?mL21 peroxidase, as previously
described [51]. The samples were excited at 540 nm and emission
measured at 585 nm with a multi-plate fluorescent plate reader at
37uC (Flexstation plate reader, Molecular Devices, USA).
Hexokinase activity assay. Hexokinase assay was per-
formed on isolated mitochondria prepared using the Polytron
method, as described previously [50]. The lysis buffer contained
33 mM KH2PO4, 50 mM dithiothreitol, protease inhibitor (cOm-
plete, mini, EDTA-free protease inhibitor cocktail, Roche, UK)
and pH 7.2. The assay was performed at 37uC and the
mitochondria were diluted to 2 mg?mL21. The hexokinase buffer
consisted of 100 mM Tris-HCl (pH 7.4) containing 0.4 mM
NADP+, 10 mM MgCl2, 5 mM ATP and 0.3% (w/v) Triton X-
100. Mitochondria (40 mg or 80 mg) were added into a cuvette
containing 1 mL final volume of hexokinase buffer supplemented
with 0.5 units?mL21 glucose-6-phosphate dehydrogenase. The
Non-Obesogenic High-Fat Diet and Cardiac Remodeling
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reaction was started after 2 min by addition of 1 mM glucose. For
one mole of glucose used by hexokinase there was one mole of
NADPH produced and therefore absorbance was recorded at
340 nm for 2 min with a spectrophotometer (Thermo Scientific,
UK).
Citrate synthase activity assay. Citrate synthase activity
assay was performed on isolated mitochondria prepared using the
Polytron method, as described previously [50]. The assay was
performed at 37uC and the mitochondria were diluted to
0.1 mg?mL-1 in lysis buffer, as above. The citrate synthase buffer
consisted of 50 mM Tris-HCl (pH 7.4), 150 mMDTNB, 0.3% (w/
v) Triton X-100 and pH 7.4. Mitochondria (2 mg or 4 mg) were
added to a cuvette containing 1 mL final volume of citrate
synthase buffer supplemented with 0.3 mM acetyl CoA. The
samples were incubated at 37uC for 2 min, a blank measurement
taken and then 0.5 mM oxaloacetate was added. Absorbance was
recorded at 412 nm for 2 min with a spectrophotometer (Thermo
Scientific, UK).
Data analysis
Data were analyzed using Prism 5 Version 5.01 software
(GraphPad, USA) and presented as mean6SEM where appro-
priate. Data were tested for normal distribution using the
Kolmogorov-Smirnov test and equal variance using the F-test.
Student’s t-test was performed on data that were normally
distributed and had equal variance. Student’s t-test with Welch’s
correction was performed on data that were normally distributed
but had unequal variance. The Mann-Whitney test was performed
on data that were not normally distributed. Fisher’s exact test was
used for categorical data. Two-way ANOVA with the Bonferroni
post-hoc test was used on data with two independent variables.
Statistical tests were performed as paired or unpaired where
appropriate. All statistical tests were performed as two-tailed and a
P-value less than 0.05 was assumed to be significantly different.
Results
Feeding C57BL/6J mice high-fat diet for 20 weeks resulted in
elevated blood cholesterol and triglycerides and was associated
with a small (,3%) but significant increase in body weight
compared to mice fed normal diet (Table 1). Most of the body
weight gain was accounted for in the increased epididymal fat pad
weights (Table 1).
The effect of high-fat diet on insulin resistance,
atherosclerosis, cardiac pump function, cardiac
hypertrophy and cardiac apoptosis
There was no evidence for a diabetic phenotype in the high-fat
diet group as shown by similar non-fasting blood glucose and
confirmed using an intra-peritoneal insulin tolerance test (Table 1).
Histological studies demonstrated that despite elevated blood lipids
the aortic sinus, brachiocephalic artery and coronary arteries had
no lesions even after longer periods of high-fat feeding (Figure S1
A–C). There were no signs of cardiac hypertrophy in the high-fat
diet group compared to the normal diet group as shown by wet
and dry heart weight to body weight ratios (Table 1). Echocar-
diographic measurements showed that cardiac pump function
(ejection fraction and fractional shortening) were similar for both
groups and no difference in the left ventricular mass (Figure S1 D–E
and Table 2).
There was no evidence for increased apoptosis in the high-fat
diet group as measured by pro- and anti-apoptotic protein levels
including Akt phosphorylation, cleaved-caspase 3, BAX and Bcl-2.
This was also confirmed by measuring BAX/Bcl-2 ratio and
mitochondrial BAX (Figure S2).
Overall, apart from high blood triglycerides and cholesterol
levels and increased epididymal fat deposits, mice fed high-fat diet
did not have obesity associated co-morbidities and had normal
cardiac pump function. As this diet does not induce marked body
weight and was not associated with any of the known obesity-
induced co-morbidities, we shall refer to it as non-obesogenic high-
fat diet.
The effect of non-obesogenic high-fat diet on
vulnerability of hearts to I/R
Hearts subjected to I/R had significantly more infarct volume
in the high-fat diet group compared to those in the normal diet
group, P,0.01 (Figure 1 A–B). The pre-ischemic flow rate values
were similar for both groups but significantly lower at the end of
reperfusion in the high-fat diet group compared to the normal diet
group, P,0.05 (Figure 1 C).
The effect of non-obesogenic high-fat diet on
vulnerability of cardiomyocytes to metabolic inhibition
Superfused cardiomyocytes isolated from mice fed high-fat diet
stopped beating and entered rigor during metabolic inhibition
(2 mM NaCN, substrate-free buffer) at earlier times compared to
cardiomyocytes from normal diet mice, P,0.001 (Figure 2 A-B).
Table 1. Characteristics of mice fed normal or high-fat diet.
Measurement Normal Diet High-Fat Diet
Body Weight (g) 31.260.2 (n = 158) 32.260.3 (n = 153)
Epididymal Fat Pad Weight (g) 0.5360.02 (n = 55) 1.1960.11*** (n = 34)
Blood Cholesterol (mM) 3.2560.20 (n = 4) 5.0660.52* (n = 4)
Blood Triglycerides (mg?dL21) 120615 (n = 4) 205626* (n = 4)
Non-Fasting blood Glucose (mM) 9.2660.64 (n = 4) 7.5460.72 (n = 4)
Area Under the IPITT Curve (mM?min) 13326149 (n = 6) 13496186 (n = 6)
Wet Heart Weight/Body Weight (%) 0.7060.13 (n = 55) 0.6860.20 (n = 34)
Dry Heart Weight/Body Weight (%) 0.10860.06 (n = 17) 0.10860.012 (n = 20)
IPITT = intra-peritoneal insulin tolerance test. Data are presented as mean6SEM. *** = P,0.001 and * = P,0.05 vs. normal diet. Numbers shown in parenthesis indicate
number of mice used except for cholesterol, triglycerides and glucose where n refers to number of measurements each containing a pool of 3 samples from 3 separate
mice.
doi:10.1371/journal.pone.0100579.t001
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Upon reperfusion, after 10 min in rigor, cardiomyocytes regained
beating (either beating or arrhythmic beating) quicker in the
normal diet group compared to high-fat diet, P,0.001 (Figure 2 C)
and regained full recovery (beating without arrhythmia) more often
than the cardiomyocytes isolated from mice fed high-fat diet, P,
0.01 (Figure 2 D).
The effect of non-obesogenic high-fat diet on oxidative
state and antioxidant proteins
Cardiac oxidative stress (MDA content) was significantly lower
in hearts from mice fed high-fat diet compared to hearts from
normal diet mice (5.0260.13 vs. 5.7060.14 nmol?mg wet
tissue21, respectively). There were only two antioxidant proteins
which had altered expression level in the high-fat diet group
compared to the normal diet group determined using proteomics:
catalase (increase) and mitochondrial superoxide dismutase 2
(SOD-2) (decrease), P,0.05 (Table 3).
The effect of non-obesogenic high-fat diet on ROS levels
in isolated cardiomyocytes and mitochondria
ROS turnover, as measured using the rate of DCF oxidation,
did not differ between the two groups when the cardiomyocytes
were incubated in HEPES buffer containing either glucose or
palmitate (Figure S3 A). Nor did hydrogen peroxide production
(measured using Amplex red) by isolated mitochondria in state 3.5
oxidizing pyruvate plus L-malate or palmitoylcarnitine plus L-
malate differ between the two groups (Figure S3 B).
The effect of non-obesogenic high-fat diet on oxygen
consumption by cardiac mitochondria in different
respiratory states
The rate of oxygen consumption fuelled by NADH from
pyruvate plus L-malate oxidation was similar for both groups
in all tested respiration states (Figure S4 A). The oxygen
consumption rates were also not different between the
normal and high-fat diet groups when comparing the b-oxidation
pathway using palmitoylcarnitine plus L-malate as substrates
(Figure S4 A). The respiratory control ratio (state 3/state 2) was
also not different between the normal and high-fat diet groups for
both sets of substrates (Figure S4 B).
The effect of non-obesogenic high-fat diet on
mitochondrial morphology
The mitochondria in the high-fat diet group were both smaller
in area and shorter in length, P,0.001 (Figure 3). The total
mitochondrial area, as a percentage of total myofilament area
(referred to as mitochondrial density), was decreased in the high-
fat diet group compared to the normal diet, P,0.05 (Figure 3).
The effect of non-obesogenic high-fat diet on
mitochondrial fusion and fission proteins
In response to the high-fat diet the expression of the fusion-
related proteins Mfn-2 and OPA1 were significantly increased and
decreased respectively, with no change in Mfn-1 expression but
an increased expression of the fission-related protein, DRP1
(Figure 4).
Table 2. Echocardiography measurements taken from mice anesthetized with isoflurane.
Measurement Normal Diet (n =7) High-Fat Diet (n=7)
Left Ventricular Mass (mg) 15267 13267
Ejection Fraction (%) 7561 7462
Fractional Shortening (%) 4361 4262
Data was obtained from M-mode echocardiographic images taken in parasternal short axis mode at the level of the papillary muscles. Data are presented as
mean6SEM. There was no statistical significance between the data.
doi:10.1371/journal.pone.0100579.t002
Figure 1. Markers of injury during I/R. A) Infarct volume quantified
from the heart slices stained with TTC. B) Representative heart slices
from the normal diet group and high-fat diet group. C) Flow rate
determined at different time points during the reperfusion phase.
Pre =pre-ischemia and grey hashed area = 40 min ischemia. Data are
presented as mean6SEM (n = 6-7 hearts). Data were analyzed using
Student’s t-test (A) and two-way repeated measures ANOVA with the
Bonferroni post-hoc test (C). ** = P,0.01 and * = P,0.05 vs. normal diet.
doi:10.1371/journal.pone.0100579.g001
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The effect of non-obesogenic high-fat diet on putative
mPTP proteins
Isolated cardiac mitochondria were assessed for the relative
expression of putative mPTP proteins using western blotting. In
the high-fat diet group there was a significant increase in the
relative protein expression of PiC and a decrease in VDAC
compared to the normal diet group, P,0.05 (Figure 5 A–B).
There was no change in both CypD and ANT in the high-fat diet
group compared to the normal diet group (Figure S5).
Figure 2. Cardiomyocyte observations and measurements during metabolic inhibition and reperfusion. Cardiomyocyte time to stop
beating (A) and time to the start of rigor (B) following metabolic inhibition (2 mM NaCN in the absence of substrates). C) Time between the start of
reperfusion and the resumption of contractile activity. D) Percentage of cardiomyocytes that had full recovery (beating without arrhythmia) following
a period of metabolic inhibition. Data are presented as mean6SEM (n$25 cardiomyocytes from at least 6 hearts). Data were analyzed using the
Mann-Whitney U test (A–C) and Fisher’s exact test (D). *** = P,0.001 and ** = P,0.01 vs. normal diet.
doi:10.1371/journal.pone.0100579.g002
Table 3. Antioxidant proteins determined using proteomics.
Protein (Accession number) Normal High-Fat Fold Change vs. Normal P-Value
Catalase (A2AL20) 0.7960.03 1.2260.13 1.54 0.02*
Isoform cytoplasmic & peroxisomal of Peroxiredoxin 5 (P99029-2) 1.0160.02 1.0260.03 1.00 0.91
Peroxiredoxin 1 (P35700) 1.0260.03 1.0760.01 1.05 0.13
Peroxiredoxin 2 (Q61171) 0.9960.02 1.0360.04 1.03 0.51
Peroxiredoxin 6 (D3Z0Y2) 0.9860.02 1.0160.02 1.03 0.32
SOD-1 (P08228) 1.1660.03 1.1560.05 0.99 0.91
SOD-2 (P09671) 1.1460.05 0.8960.06 0.78 0.02*
Thioredoxin-dependent peroxide reductase, mitochondrial (P20108) 0.9860.03 1.0360.01 1.05 0.13
Data are presented as mean6SEM (n = 4 hearts) and are relative to the pooled sample and normalized to GAPDH. Data were analyzed using Student’s t-test. * = P,0.05
vs. normal diet.
doi:10.1371/journal.pone.0100579.t003
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The effect of non-obesogenic high-fat diet on
mitochondrial hexokinase protein content and activity
There was less hexokinase II protein at the mitochondrial level
in the high-fat diet group compared to the normal diet group, P,
0.05 (Figure 5 C). The hexokinase activity at the mitochondrial
level was also significantly lower in the high-fat diet group
compared to the normal diet group, P,0.05 (Figure 5 D).
The effect of non-obesogenic high-fat diet on diastolic
intracellular Ca2+
The diastolic [Ca2+]i in isolated cardiomyocytes was elevated in
the high-fat diet group compared to the normal diet group at all
frequencies tested, P,0.05 (Figure 6 B). To consider the difference
at 0.2 Hz the diastolic [Ca2+]i was also presented as diastolic
[Ca2+]i with the 0.2 Hz [Ca
2+]i subtracted. This showed that as
the frequency increased the difference between the normal diet
and high-fat diet became larger and became significant at 2.0 Hz
(Figure 6 C). The level of phospholamban phosphorylation (Ser16)
decreased in the high-fat diet compared to normal diet, P,0.05
(Figure 6 D).
The changes in catalase, MDA and the efficacy of CsA
during I/R
Cardiac oxidative stress (MDA content) significantly increased
at the end of I/R reaching similar levels for both hearts isolated
from mice fed normal or high-fat diet (Figure 7 A). However, the
relative change during I/R was more pronounced in the high-fat
diet compared to the normal diet (increased by 18% and 36%, for
normal and high-fat diet, respectively). In contrast, catalase
expression which was significantly higher in hearts from high-fat
diet did not change during I/R, whereas in the normal diet group
there was a doubling of catalase at the end of I/R compared to
basal levels, P,0.05 (Figure 7 B and S6).
CsA significantly decreased infarct size in the normal diet and
high-fat diet groups, P,0.001 (Figure 8 A–B). However the extent
of the protection was more marked for high-fat diet (from
69.161.3 to 40.362.1% infarct volume) compared to normal diet
(from 54.663.4 to 36.362.1% infarct volume). Finally, CsA did
not alter the recovery in flow rate in the normal diet group
whereas in the high-fat diet group the flow rate recovery after an
I/R protocol was significantly improved (Figure 8 C).
Discussion
The overwhelming majority of experimental studies investigat-
ing the effect of elevated plasma lipids on cardiac pump
remodeling have used models of obesity where cellular, functional
and structural cardiac changes can be attributed to obesity-
associated co-morbidities. Subsequently, the reported increase in
vulnerability to I/R of hearts from animals fed high-fat diet has
been explained in terms of obesity related effects (e.g. diabetes,
cardiac hypertrophy) as well as lipid-induced direct effects on the
heart. What has been lacking thus far is a model of hyperlipidemia
Figure 3. Representative electron micrographs of mitochondria and measurements. Representative electron micrographs from mice fed
normal diet (A) and high-fat diet (B). Individual mitochondrion area (C) and length (D) and mitochondrial coverage of myofilament area (E) assessed
using transmission electron micrographs. Data are presented as mean6SEM (n = 4 hearts and $900 mitochondria per heart from $10 electron
micrographs per heart). Data were analyzed using Mann Whitney U test (C–D) and Student’s t-test (E). *** = P,0.001 and * = P,0.05 vs. normal diet.
doi:10.1371/journal.pone.0100579.g003
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and hypercholesterolemia with no obesity to directly determine
lipid-induced cardiac remodeling in the context of vulnerability to
cardiac insults. In this study, we have shown for the first time that
high-fat diet, independent of obesity-induced co-morbidities,
increases the vulnerability of both isolated hearts and cardiomy-
ocytes to cardiac insults. Furthermore, high-fat diet triggered
cellular changes (raised [Ca2+]i, oxidative stress during I/R,
hexokinase II dissociation from the mitochondria and mitochon-
drial fragmentation) that can contribute to increased vulnerability
by altering mPTP opening during I/R.
A non-obese mouse model of hyperlipidemia and
hypercholesterolemia
In this study we characterized a mouse model of hyperlipidemia
and hypercholesterolemia that is not obese and does not show key
obesity-associated morbidities. The 20 week duration of high-fat
feeding was not sufficient to induce diabetes, coronary disease,
cardiac hypertrophy, apoptosis or alter cardiac pump function. In
this model the body weight increased by 3% whereas models of
obesity in mice see an increase in body weight to 40 g (30%
increase) or more [52,53]. This was achieved by feeding mice a
high-fat, very low sucrose diet for 20 weeks. Using high sucrose
instead of starch in normal or high-fat diet appears to be key in
triggering significant weight gain/obesity ([33] and see Introduc-
tion). Consistent with this is the original work by Surwit et al. [54]
showing significant obesity and diabetes in C57BL/6J mice using
disaccharides as the primary source of carbohydrate.
Increased vulnerability of hearts and cardiomyocytes to
cardiac insults
Isolated hearts and cardiomyocytes from mice fed high-fat diet
had increased vulnerability to cardiac insults compared to those
fed normal diet. This is similar to earlier studies on animals fed
high-fat diet causing obesity [18]. However, in this study the
triggers will be largely due to hyperlipidemia induced cardiac
cellular remodeling independent of obesity. The increased
vulnerability to I/R in our study is unlikely to be due to the
absence of fatty acids from the perfusate as an earlier study
demonstrated increased vulnerability even in the presence of an in
vivo circulating concentrations of lipids [25]. Myocardial I/R
injury, which can occur during clinical procedures such as
thrombolysis, angioplasty and coronary artery bypass graft
surgery, is triggered by significant Ca2+ overload and oxidative
stress that lead to mPTP opening [23,24]. High-fat diet has been
shown to induce oxidative stress [13] which may augment Ca2+
overload and I/R injury [55,56].
Figure 4. The relative cardiac protein expression of mitochondrial fusion and fission proteins determined using western blotting.
The fusion proteins were Mfn-1 (A), Mfn-2 (B) and OPA1 (C) and the fission protein was DRP1 (D). Protein bands were normalized to GAPDH. Data are
presented as mean6SEM (n= 6 hearts). Data were analyzed using Student’s t-test (A, B and D) and Student’s t-test with Welch’s correction (C).
*** = P,0.001 and * = P,0.05 vs. normal diet.
doi:10.1371/journal.pone.0100579.g004
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Non-obesogenic high-fat diet increases vulnerability to
oxidative stress during I/R
Cardiac oxidative stress and increased catalase levels are closely
linked to increased fat metabolism associated with high-fat diet
and obesity [57–59]. A surprising finding in this study was that
feeding mice non-obesogenic high-fat diet for 20 weeks actually
lowered the level of myocardial lipid peroxidation compared to
control. Decreased ROS in other tissues from high-fat feeding has
already been reported and has been attributed to increasing
proliferation of peroxisomes and thus catalase levels [60]. The
marked increase in cardiac catalase expression in our high-fat diet
model (nearly 5 fold, Figure 7) is likely to be responsible for the
relatively lower MDA levels. Apart from a fall in SOD-2 there was
no difference in the expression of other antioxidant enzymes
(Table 3).
Both lower cardiac MDA and higher catalase are expected to
render the heart more resistant to I/R injury. However, we found
hearts from high-fat diet mice were more vulnerable to I/R and
less able to cope with oxidative stress as shown by inability to
increase the levels of catalase compared to normal diet (Figure 7).
Thus it would appear that hearts of mice fed non-obesogenic high-
fat diet had already upregulated catalase in response to the diet
and therefore were not able to adapt to a further increase in
oxidative stress during I/R. In contrast, and because the basal
level of cardiac catalase was relatively low, hearts from normal diet
mice were able to increase catalase protein expression during I/R.
This work clearly suggests that elevated catalase prior to I/R is
only important if the levels of the enzyme can be further
augmented during the cardiac insult.
Non-obesogenic high-fat diet triggers mitochondrial
fragmentation and disruption to Ca2+ cycling
Myocardial mitochondria are a major source for ROS
production during I/R (reviewed in [61]) and any changes in
their structure and function during high-fat feeding might impact
on ROS production and vulnerability to I/R. Our data indicate
that despite changes to substrate supply in high-fat diet group,
isolated mitochondria retain the capacity to oxidize different
substrates to a similar level as control (Figure S4). These findings
are similar to those reported for high-fat diet induced obesity
models [62,63], although there are reports indicating differences in
oxygen consumption [64].
The interfibrillar mitochondria from mice fed a high-fat diet
were smaller, shorter and covered less myofilament area compared
to the normal diet group which is suggestive of mitochondrial
fission. However, the changes observed in fusion and fission
proteins did not present a clear picture of how this might be
achieved. Reduced OPA1 indicates fission although there are
reports suggesting less OPA1 increases the size of the mitochon-
dria [65]. Elevated Mfn-2 levels are also indicative of fission as
Figure 5. Relative cardiac protein expression of putative mitochondrial permeability transition pore components/regulators. PiC (A),
VDAC (B), mitochondrial hexokinase II protein (C) and mitochondrial hexokinase activity (D). Data are presented as mean6SEM (n= 5 mitochondrial
isolations). Data were analyzed using Student’s t-test with Welch’s correction (A) and Student’s t-test (B–D). * = P,0.05 vs. normal diet.
doi:10.1371/journal.pone.0100579.g005
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Figure 6. The diastolic intracellular Ca2+ concentration measured using Fura-2 AM fluorescence in isolated cardiomyocytes. A) An
example trace of Ca2+ transients using the Fura-2 fluorescent dye. The cell was stimulated at the frequencies indicated. B) Diastolic [Ca2+]i at different
frequencies in isolated cardiomyocytes. C) Diastolic [Ca2+]i with the 0.2 Hz diastolic [Ca
2+]i subtracted. D) The relative phosphorylated
phospholamban (P-PLN Ser16) to phospholamban (PLN) protein expression ratio. Data are presented as mean6SEM (n= 29–32 cardiomyocytes
from 4 hearts (B–C) and 6 hearts (D)). Data were analyzed using two-way ANOVA with the Bonferroni post-hoc test (B–C) and Student’s t-test (D).
*** = P,0.001, ** = P,0.01 and * = P,0.05 vs. normal diet.
doi:10.1371/journal.pone.0100579.g006
Figure 7. Oxidative state during I/R. A) MDA measurements in unperfused heart tissue or hearts collected at the end of an I/R protocol analyzed
using HPLC. B) The relative catalase protein expression at basal level and after I/R determined using western blotting with all sample run on the same
membrane. Data are presented as mean6SEM (n= 5–6 hearts (A) and 3 hearts (B)). Data were analyzed using two-way ANOVA with the Bonferroni
post-hoc test (A). *** = P,0.001, ** = P,0.01, * = P,0.05 vs. basal, $$$=P,0.001, $$=P,0.01and $=P,0.05 vs. normal diet.
doi:10.1371/journal.pone.0100579.g007
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Mfn-2 knockout mouse have been reported have larger and longer
mitochondria [66]. Mfn-2 is involved in tethering the endoplasmic
reticulum with the mitochondria [67] and this might create a pool
of higher concentration of Ca2+ around the mitochondria.
Elevated Ca2+ has been reported to recruit DRP1 to mitochondria
and induce fission [68] as well as making them more likely to
experience Ca2+ overload [69]. Consistent with this, cardiomyo-
cytes from the Mfn-2 knockout mice are more resistant to
simulated I/R [70]. It has been proposed that larger mitochondria
are able to accommodate Ca2+ loading better during I/R and
therefore reduce cell death [71] whilst mitochondrial fragmenta-
tion increases rate of ROS production [68,72]. Overall, the
increase in cardiac Mfn-2 in high-fat diet is consistent with
increased fission and vulnerability to I/R.
In addition to ROS generation, Ca2+ overload is also a key
determinant of I/R injury. Cardiomyocytes from high-fat diet had
higher diastolic [Ca2+]i compared to normal diet (Figure 6). The
finding that these hearts have reduced phosphorylated phospho-
lamban suggests that it may be impairment in sarcoplasmic
reticulum function that leads to higher levels of [Ca2+]i.
Generation of ROS has been implicated in Ca2+ handling defects
including depressed Ca2+ uptake by the sarcoplasmic reticulum
[73,74]. The impairment of coronary flow in the isolated hearts
during reperfusion in the high-fat diet group is likely to be a result
of increase in vascular resistance caused by increased contracture
(diastolic dysfunction). Diastolic dysfunction during reperfusion is
strongly linked to Ca2+ overload [75] which is likely to lead to a
raised mitochondrial Ca2+ content. Along with ROS production,
Ca2+ loading would render the mPTP more prone to opening
during I/R [76].
A role for the mitochondrial permeability transition pore
in increased vulnerability to I/R
Cardiac remodeling in response to high-fat diet indicates
changes that would increase mPTP opening. However, there
was also direct evidence showing significant changes in the
expression levels of mitochondrial proteins implicated as compo-
nents and regulators of the mPTP. High-fat diet reduced
mitochondrial hexokinase II activity and expression compared to
the normal diet group. Hexokinase II is a metabolic sensor and
therefore altering the diet would change the substrate supply
which could alter the localization of hexokinase II [77].
Mitochondrial hexokinase II content is important during I/R
injury as the amount at the end of ischemia negatively correlates
Figure 8. I/R injury in isolated hearts with and without the addition of 0.2 mM CsA. The CsA was added to the buffer 10 min before
ischemia and remained until 20 min after ischemia. A) Infarct volume quantified from the heart slices stained with TTC. B) Representative heart slices
from the normal diet and high-fat diet groups. C) The change in flow rate from pre-ischemia to the end of reperfusion. Data are presented as
mean6SEM (n= 5-6 hearts). Data were analyzed using two-way ANOVA with the Bonferroni post-hoc test. *** = P,0.001, ** = P,0.01 vs. normal diet,
$$$=P,0.001 and $=P,0.05 vs. CsA.
doi:10.1371/journal.pone.0100579.g008
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with infarct size [50]. The loss of mitochondrial hexokinase II is
thought to destabilize mitochondrial contact sites which induces
outer mitochondrial membrane permeability [50].
Key putative components of mPTP were also altered by high-fat
diet. There was a significant decrease in the expression of VDAC,
an increase in mitochondrial PiC but no change in CypD and
ANT. Not only does the PiC transport phosphate into the matrix
of the mitochondria where it can activate the mPTP; it has also
been proposed to be a component of the mPTP structure [76,78].
VDAC is the proposed binding site for hexokinase [79]. Therefore
a reduction in VDAC protein might be a reason for the decreased
amount of hexokinase II binding at the mitochondria. Whether
changes to the components of the mPTP would have an impact on
the amount of mPTP opening is not presently known. However,
opening of the mPTP can lead to further ROS production through
loss of cytochrome c and this can generate a positive feedback loop
of ROS formation and mPTP opening [51].
Our data are consistent with the proposal that feeding mice
non-obesogenic high-fat diet for a period of 20 weeks triggers
cardiac remodeling which increases the sensitivity of the mPTP to
open during I/R. This is consistent with CsA showing relatively
more efficacy in protecting the heart in high-fat diet group
compared to the normal diet group.
In conclusion, feeding mice non-obesogenic high-fat diet
increases the vulnerability of both isolated hearts and cardiomy-
ocytes to cardiac insults. A number of factors (raised [Ca2+]i,
oxidative stress during I/R, hexokinase II dissociation from the
mitochondria and mitochondrial fragmentation) in the high-fat
diet group can contribute to this effect possibly by altering mPTP
opening during I/R [50,76,80].
Supporting Information
Figure S1 Representative histology and echocardiogra-
phy images. Representative aortic sinus (A), brachiocephalic
artery (B) and coronary arteries (C) from mice fed high-fat diet.
Sections are stained with elastic van Gieson; purple = elastin and
red= connective tissue. Arrow head points to elastin. Scale
bars = 200 mm. Representative echocardiographic traces from
normal diet (D) and high-fat diet (E) mice. M-mode echocardio-
graphic measurements were taken in the parasternal short axis
view at the level of the papillary muscles.
(TIF)
Figure S2 The relative cardiac protein expression of
apoptotic markers determined using western blotting.
The relative protein expression of P-Akt (Ser473)/Akt ratio (A),
cleaved-caspase 3 (CC3) (B), mitochondrial BAX (C) and BAX/
Bcl-2 ratio (D) normalized to GAPDH or total protein blots. Data
are presented as mean6SEM (n= 5–6 hearts). Data were analyzed
using the Mann-Whitney U test (A–B and D) and Student’s t-test
(C). There was no statistical significance between the data.
(TIF)
Figure S3 Reactive oxygen species production in isolat-
ed cardiomyocytes and isolated mitochondria. A) DCF
fluorescence measurements in quiescent cardiomyocytes using
HEPES buffer containing either glucose or palmitate. B)
Hydrogen peroxide production in isolated cardiac mitochondria
using either pyruvate/L-malate (P/M) or palmitoylcarnitine/L-
malate (Pal-Car). Data are presented as mean6SEM (n= 5-7
isolations). Data were analyzed using the Mann-Whitney U test (A)
and Student’s t-test (B). There was no statistical significance
between the data.
(TIF)
Figure S4 Mitochondrial oxygen consumption in differ-
ent respiration states using different energy substrates.
Oxygen consumption was measured using an Oxygraph. A)
Oxygen consumption in state 2, state 3.5 and state 3. The
respiratory control ratio was calculated using the state 3:state 2
ratio (B). P/M=pyruvate/L-malate and Pal-Car = palmitoylcar-
nitine/L-malate. Data are presented as mean6SEM (n=5
mitochondrial isolations). Data were analyzed using Student’s t-
test. There was no statistical significance between the data.
(TIF)
Figure S5 Relative cardiac protein expression of puta-
tive mitochondrial permeability transition pore compo-
nents/regulators determined using western blotting.
CypD (A) and ANT (B) normalized to total protein blots. Data
are presented as mean6SEM (n=5 mitochondrial isolations).
Data were analyzed using Student’s t-test (A) and the Mann-
Whitney U test (B). There was no statistical significance between
the data.
(TIF)
Figure S6 The relative cardiac catalase protein levels at
the basal level and after I/R. Basal levels of catalase (A) and
catalase after I/R (B) normalized to GAPDH. Data are presented
as mean6SEM (n=6 hearts). Data were analyzed using Student’s
t-test with Welch’s correction. *** = P,0.001 and *=P,0.05 vs.
normal diet.
(TIF)
Table S1 High-fat diet (Special Diets Services code:
821424) formulation and specification data for guidance.
(DOCX)
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